ContractMaster Manufacturing Services and Supply Agreement • May 5th, 2020
EX-10.13 3 kerx12312017-10kex1013.htm EXHIBIT 10.13 Exhibit 10.13 MASTER MANUFACTURING SERVICES AND SUPPLY AGREEMENT This Master Manufacturing Services and Supply Agreement (this “Agreement”) is entered into as of the date of last signature (the “Agreement Date”), by and between Siegfried Evionnaz SA (together with its Affiliates and subsidiaries, “Vendor”), with principal offices located at Route du Simplon 1, 36, 1902 Evionnaz, Switzerland, and Keryx Biopharmaceuticals, Inc. (together with its Affiliates and subsidiaries, “Keryx”), with principal offices located at One Marina Park Drive, 12th Floor, Boston, MA 02210, USA. WHEREAS, the Parties hereto desire that Vendor provide Keryx with certain services and create certain deliverables, from time to time in accordance with the terms and conditions of this Agreement. NOW, THEREFORE, in consideration of the agreements and the mutual covenants contained in this Agreement and for other good and valuable consideration, the receipt and suff
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. AMENDMENT NO. 5 TO...Master Manufacturing Services and Supply Agreement • May 8th, 2023 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 5 to Master Manufacturing Services and Supply Agreement (“Amendment No. 5”) is made effective and entered into on February 28, 2023 (the “Amendment No. 5 Effective Date”) by and between Siegfried Evionnaz SA, with principal offices located at Route du Simplon 1, 36, 1902 Evionnaz, Switzerland (together with its Affiliates and subsidiaries “Vendor”); and Keryx Biopharmaceuticals, Inc., with its offices at 245 First Street, Cambridge, Massachusetts, USA 02142 (“Keryx”).
AMENDMENT NO. 1 TO MASTER MANUFACTURING SERVICES AND SUPPLY AGREEMENTMaster Manufacturing Services and Supply Agreement • February 25th, 2021 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 1 to Master Manufacturing Services and Supply Agreement (“Amendment No. 1”) is made effective and entered into on December 21, 2020 (the “Amendment Effective Date”) by and between Siegfried Evionnaz SA, with principal offices located at Route du Simplon 1, 36, 1902 Evionnaz, Switzerland (together with its Affiliates and subsidiaries “Vendor”); and Keryx Biopharmaceuticals, Inc., with its offices at 245 First Street, Cambridge, Massachusetts, USA 02142 (“Keryx”).
AMENDMENT NO. 4 TO MASTER MANUFACTURING SERVICES AND SUPPLY AGREEMENTMaster Manufacturing Services and Supply Agreement • March 1st, 2022 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 4 to Master Manufacturing Services and Supply Agreement (“Amendment No. 4”) is made effective and entered into on December 17, 2021 (the “Amendment Effective Date”) by and between Siegfried Evionnaz SA, with principal offices located at Route du Simplon 1, 36, 1902 Evionnaz, Switzerland (together with its Affiliates and subsidiaries “Vendor”); and Keryx Biopharmaceuticals, Inc., with its offices at 245 First Street, Cambridge, Massachusetts, USA 02142 (“Keryx”).
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. AMENDMENT NO. 3 TO MASTER...Master Manufacturing Services and Supply Agreement • February 25th, 2021 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 3 to Master Manufacturing Services and Supply Agreement (“Amendment No. 3”) is made effective and entered into on February 11, 2021 (the “Amendment Effective Date”) by and between Siegfried Evionnaz SA, with principal offices located at Route du Simplon 1, 36, 1902 Evionnaz, Switzerland (together with its Affiliates and subsidiaries “Vendor”); and Keryx Biopharmaceuticals, Inc., with its offices at 245 First Street, Cambridge, Massachusetts, USA 02142 (“Keryx”).
AMENDMENT NO. 2 TO MASTER MANUFACTURING SERVICES AND SUPPLY AGREEMENTMaster Manufacturing Services and Supply Agreement • February 25th, 2021 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 2 to Master Manufacturing Services and Supply Agreement (“Amendment No. 2”) is made effective and entered into on January 29, 2021 (the “Amendment Effective Date”) by and between Siegfried Evionnaz SA, with principal offices located at Route du Simplon 1, 36, 1902 Evionnaz, Switzerland (together with its Affiliates and subsidiaries “Vendor”); and Keryx Biopharmaceuticals, Inc., with its offices at 245 First Street, Cambridge, Massachusetts, USA 02142 (“Keryx”).
